During the past decade, Mercy Cancer Center - Elk Grove conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Cancer Center - Elk Grove" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "SWOG Cancer Research Network" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "NRG Oncology" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Cancer Center - Elk Grove" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Cancer Center - Elk Grove" are "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (3 trials), "Ovarian Seromucinous Carcinoma" (2 trials) and "Recurrent Fallopian Tube Carcinoma" (2 trials). Many other conditions were trialed in "Mercy Cancer Center - Elk Grove" in a lesser frequency.

Most popular intervention types in "Mercy Cancer Center - Elk Grove" are "Drug" (13 trials), "Other" (12 trials), "Biological" (4 trials), "Procedure" (4 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (4 trials), "Laboratory Biomarker Analysis" (4 trials), "Cisplatin" (3 trials), "Clinical Observation" (3 trials) and "Placebo Administration" (3 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Cancer Center - Elk Grove" are 10 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Cancer Center - Elk Grove". undefined are not yet recruiting, 5 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Mercy Cancer Center - Elk Grove, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Cancer Center - Elk Grove, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".